123 related articles for article (PubMed ID: 17987225)
21. Applications for preclinical PET/MRI.
Judenhofer MS; Cherry SR
Semin Nucl Med; 2013 Jan; 43(1):19-29. PubMed ID: 23178086
[TBL] [Abstract][Full Text] [Related]
22. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
23. [Positron emission tomography/magnetic resonance: Present and future].
Kohan AA; Vercher Conejero JL; Gaeta MC; Pelegrí Martinez L; Ros PR
Rev Esp Med Nucl Imagen Mol; 2013; 32(3):167-76. PubMed ID: 23582491
[TBL] [Abstract][Full Text] [Related]
24. PET/MRI: a new technology in the field of molecular imaging.
Afaq A; Syed R; Bomanji J
Br Med Bull; 2013; 108():159-71. PubMed ID: 24227824
[TBL] [Abstract][Full Text] [Related]
25. PET/MRI of the heart.
Rischpler C; Nekolla SG; Kunze KP; Schwaiger M
Semin Nucl Med; 2015 May; 45(3):234-47. PubMed ID: 25841278
[TBL] [Abstract][Full Text] [Related]
26. The role of positron emission tomography in the discovery and development of new drugs; as studied in laboratory animals.
Roselt P; Meikle S; Kassiou M
Eur J Drug Metab Pharmacokinet; 2004; 29(1):1-6. PubMed ID: 15151164
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the Efficacy of Targeted Imaging Agents.
Graham MM; Weber WA
J Nucl Med; 2016 Apr; 57(4):653-9. PubMed ID: 26769867
[TBL] [Abstract][Full Text] [Related]
28. Promoting, improving and accelerating the drug development and approval processes.
Graul AI
Drug News Perspect; 2008; 21(1):36-43. PubMed ID: 18301808
[TBL] [Abstract][Full Text] [Related]
29. Whole body simultaneous PET/MRI: one-stop-shop?
Maseeh-uz-Zaman ; Fatima N; Sajjad Z; Zaman U
J Pak Med Assoc; 2014 Feb; 64(2):201-4. PubMed ID: 24640813
[TBL] [Abstract][Full Text] [Related]
30. Vision 20/20: Magnetic resonance imaging-guided attenuation correction in PET/MRI: Challenges, solutions, and opportunities.
Mehranian A; Arabi H; Zaidi H
Med Phys; 2016 Mar; 43(3):1130-55. PubMed ID: 26936700
[TBL] [Abstract][Full Text] [Related]
31. The role of molecular imaging in drug discovery and development.
Hargreaves RJ
Clin Pharmacol Ther; 2008 Feb; 83(2):349-53. PubMed ID: 18167503
[TBL] [Abstract][Full Text] [Related]
32. Translational PET imaging research.
Hargreaves RJ; Rabiner EA
Neurobiol Dis; 2014 Jan; 61():32-8. PubMed ID: 24055214
[TBL] [Abstract][Full Text] [Related]
33. Positron emission tomography imaging as a key enabling technology in drug development.
McCarthy TJ
Ernst Schering Res Found Workshop; 2007; (62):329-39. PubMed ID: 17172162
[TBL] [Abstract][Full Text] [Related]
34. PET/MR in dementia and other neurodegenerative diseases.
Barthel H; Schroeter ML; Hoffmann KT; Sabri O
Semin Nucl Med; 2015 May; 45(3):224-33. PubMed ID: 25841277
[TBL] [Abstract][Full Text] [Related]
35. PET/MRI: challenges, solutions and perspectives.
Herzog H
Z Med Phys; 2012 Dec; 22(4):281-98. PubMed ID: 22925652
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
[TBL] [Abstract][Full Text] [Related]
37. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
38. PET/MRI: Emerging Clinical Applications in Oncology.
Fraum TJ; Fowler KJ; McConathy J
Acad Radiol; 2016 Feb; 23(2):220-36. PubMed ID: 26521689
[TBL] [Abstract][Full Text] [Related]
39. PET/MR - a rapidly growing technique of imaging in oncology and neurology.
Sałyga A; Guzikowska-Ruszkowska I; Czepczyński R; Ruchała M
Nucl Med Rev Cent East Eur; 2016; 19(1):37-41. PubMed ID: 26841378
[TBL] [Abstract][Full Text] [Related]
40. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
